2026 Accreditation
Focal Therapy
2026 Focal Annual Meeting
LIVE: September 24-26, 2026 -San Diego, CA
ENDURING: Online September 27, 2026 – March 27, 2027
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Focal Therapy. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation Provider Number: 4008163
Professions in scope for this activity are listed below.
Physicians
LIVE: Amedco LLC designates this live activity for a maximum of 18.75 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ENDURING: Amedco LLC designates this material for a maximum of 17.25 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.
Physicians
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification for PAs.
LIVE: Amedco LLC designates this live activity for a maximum of 18.75 AMA PRA Category 1 Credits™. PAs should claim only the credit commensurate with the extent of their participation in the activity.
ENDURING: Amedco LLC designates this enduring activity for a maximum of 17.25 AMA PRA Category 1 Credits™. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Objectives – After Attending This Program You Should Be Able To
- Describe the rationale, the latest evidence on oncological and functional outcomes, surveillance strategies and management of the complications of focal therapy.
- Describe the indications, preoperative evaluation, surgical steps/procedure, and expected patient outcomes for various minimally invasive operations for BPH.
- Describe guideline concordant management of metastatic prostate
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)
All individuals in a position to control the content of CE are listed below.
Name |
Commercial Interest:Relationship |
|---|---|
| Aaron Abrams | NA |
| Aditya Bagrodia | veracyte, ferring, urogen:Consultant |
| Giovanni Cacciamani | EditorAiPro:Owner |
| Sharon Choi | NA |
| Bilal Chughtai | Promaxo, Bright Uro, COSM:Scientific/Medical Advisory Board Member; Femselect, ARMs, BSC, Olympus, Prodeon Medical, Sumitomo, Zenflow:Consultant; BSC, Abbvie:Research Grant Site Principal Investigator |
| Justin Cohen | Johnson and Johnson:Speakers Bureau; Pfizer, Johnson and Johnson:Scientific/Medical Advisory Board Member |
| Matthew Cooperberg | LynxDx, Exosome Dx, BlueEarth, Bayer, Janssen, Astra-Zeneca, Johnson&Johnson, Pfizer, GlaxoSmithKline:Consultant |
| John Michael DiBianco | Richard Wolf, Boston Scientific:Consultant; Virtuso:Public Stock Shareholder |
| Furkan Dursun | NA |
| Scott Eggener | A3P Biomedical:Private Stock Shareholder; A3P Biomedical:Research Grant Site Principal Investigator; A3P Biomedical:Scientific/Medical Advisory Board Member; Telix:Research Grant Overall Principal Investigator |
| Geo Espinosa | XYwellness, LLC:Stock Shareholder |
| Nicholas Feinberg | GE Health:Consultant |
| Zachary Feuer | NA |
| Daniel Frendl | EDAP/FocalOne, Angiodynamics, Boston Scientific, BD Sciences, BlueEarth:Consultant; FrancisMedical:Research Grant Site Principal Investigator |
| Joel Funk | Boston Scientific Corporation, Richard Wolf USA, Andromeda Surgical:Consultant |
| Krish Gaitonde | NA |
| Arvin George | Veracyte, Sonablate Corporation, HIFU Prostate Services, CIVCO, BK Medical, Lina Med, Boston Scientific, Koelis:Consultant; Levee Medical, Angiodynamics, Francis Medical:Research Grant Overall Principal Investigator; Lantheus Medical:Research Grant Site Principal Investigator; Histosonics, Fortec Medical, Philips Medical:Consultant; Profound Medical:Speakers Bureau |
| Sandeep Gurram | NA |
| Andrew Hung | Medtronic:Consultant |
| Christian Lee | NA |
| Christopher Lee | NA |
| Kaitlyn Lee | NA |
| Michael Liss | Koelis:Consultant; Oncobiomix:Owner |
| Benjamin Martin | Bayer, Astra Zeneca, Dendreon:Speakers Bureau; Ferring:Other |
| Par Mehta | NA |
| Zham Okhunov | NA |
| Aytekin Oto | Profound:Scientific/Medical Advisory Board Member |
| Peter Pinto | Philips:Patent Holder |
| Soroush Rais-Bahrami | Artera AI, Bayer Healthcare, Blue Earth Diagnostics, Boston Scientific, Cardinal Health, Ferring Pharma, Intuitive Surgical, Philips Corp, Progenies:Consultant |
| Pawel Rajwa | Astellas, Jansen, Bayer:Speakers Bureau |
| Deepika Reddy | Sonablate Corp:Other |
| George Schade | EDAP/Focal One:Consultant; Petal Surgical:Scientific/Medical Advisory Board Member |
| Abhinav Sidana | Janssen Oncology, Astrazeneca:Speakers Bureau; Abbvie, EDAP, Angiodynamics:Consultant; Astellas, Pfizer:Scientific/Medical Advisory Board Member |
| Mohummad Siddiqui | NA |
| Ilya Sobol | Storz, Ambu, Cook:Consultant |
| Geoffrey Sonn | NA |
| Baris Turkbey | NVIDIA, Philips:Other |
| sadhna verma | NA |
| Srinivas Vourganti | Fortec, Philips, Biobot, Axogen:Consultant; Philips, Biobot:Speakers Bureau |
| Kara Watts | NA |
| Bristol Whiles | Boston Scientific, Karl Storz, Mokan Labs, LLC, Cook, HugeMed / InterMed:Consultant; Evolve Consortium:Owner |
| Karla Witzke | Olympus:Speakers Bureau |
| Michael Yip | Channel Robotics, Humane Robotics, Yip Consulting Services:Owner |
| Kevin Zorn | NA |
| Tracy Peterson | NA |